232 related articles for article (PubMed ID: 15048141)
1. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs.
Heim D; Baldomero H; Medinger M; Masouridi-Levrat S; Schanz U; Nair G; Güngör T; Halter J; Passweg JR; Chalandon Y;
Swiss Med Wkly; 2024 May; 154():3754. PubMed ID: 38749067
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Choices in Patients with Ph-Positive Chronic Myelogenous Leukemia In Mexico in the Era of Tyrosine Kinase Inhibitors: Stem Cell Transplantation or Tyrosine Kinase Inhibitors? Fifteen Years Later.
Max RN; Daniela SB; Moisés M GP; Edgar J HF; Merittzel A MR; María de L PM; Juan C OG; Guillermo J RD; Guillermo J RA
Rev Invest Clin; 2024; 76(2):91-96. PubMed ID: 38740380
[TBL] [Abstract][Full Text] [Related]
4. Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission.
Seftel MD; Neuberg D; Zhang MJ; Wang HL; Ballen KK; Bergeron J; Couban S; Freytes CO; Hamadani M; Kharfan-Dabaja MA; Lazarus HM; Nishihori T; Paulson K; Saber W; Sallan SE; Soiffer R; Tallman MS; Woolfrey AE; DeAngelo DJ; Weisdorf DJ;
Am J Hematol; 2016 Mar; 91(3):322-9. PubMed ID: 26701142
[TBL] [Abstract][Full Text] [Related]
5. [Clinical outcomes of allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia].
Zhang XH; Zhou JY
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):18-21. PubMed ID: 38527833
[TBL] [Abstract][Full Text] [Related]
6. Chronic myeloid leukemia 2011: successes, challenges, and strategies--proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop.
Mughal TI; Radich JP; Van Etten RA; Quintás-Cardama A; Skorski T; Ravandi F; DeAngelo DJ; Gambacorti-Passerini C; Martinelli G; Tefferi A
Am J Hematol; 2011 Sep; 86(9):811-9. PubMed ID: 21850662
[TBL] [Abstract][Full Text] [Related]
7. Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis.
Gupta V; Gotlib J; Radich JP; Kröger NM; Rondelli D; Verstovsek S; Deeg HJ
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1274-81. PubMed ID: 24680977
[TBL] [Abstract][Full Text] [Related]
8. Novel strategies for the treatment of myelofibrosis driven by recent advances in understanding the role of the microenvironment in its etiology.
Eran Z; Zingariello M; Bochicchio MT; Bardelli C; Migliaccio AR
F1000Res; 2019; 8():. PubMed ID: 31583083
[TBL] [Abstract][Full Text] [Related]
9. Chronic myeloid leukemia with a significant increase of monocytes and rare karyotype: A case report and literature review.
Zhang Y; Tan Q; Cao P; Chen C; Chen W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 46(3):322-327. PubMed ID: 33927081
[TBL] [Abstract][Full Text] [Related]
10. Chronic myelomonocytic leukemia: Forefront of the field in 2015.
Benton CB; Nazha A; Pemmaraju N; Garcia-Manero G
Crit Rev Oncol Hematol; 2015 Aug; 95(2):222-42. PubMed ID: 25869097
[TBL] [Abstract][Full Text] [Related]
11. Are transplant indications changing for myelofibrosis?
Palmer J
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):676-681. PubMed ID: 38066916
[TBL] [Abstract][Full Text] [Related]
12. Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Vannucchi AM; Barbui T; Cervantes F; Harrison C; Kiladjian JJ; Kröger N; Thiele J; Buske C;
Ann Oncol; 2015 Sep; 26 Suppl 5():v85-99. PubMed ID: 26242182
[No Abstract] [Full Text] [Related]
13. Predictors of neuropsychological change in patients with chronic myelogenous leukemia and myelodysplastic syndrome.
Meadows ME; Chang G; Jones JA; Antin JR; Orav EJ
Arch Clin Neuropsychol; 2013 Jun; 28(4):363-74. PubMed ID: 23391504
[TBL] [Abstract][Full Text] [Related]
14. Donor cell-derived chronic myelomonocytic leukemia presenting after allogeneic hematopoietic cell transplantation for T-cell acute lymphoblastic leukemia.
Miller KC; Abdel Rahman ZH; Robetorye RS; Foran JM
Clin Case Rep; 2020 Dec; 8(12):3225-3228. PubMed ID: 33363911
[TBL] [Abstract][Full Text] [Related]
15. Robin M, de Wreede LC, Padron E, et al. Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis. Blood. 2022;140(12):1408-1418.
Blood; 2023 Jun; 141(26):3232-3233. PubMed ID: 37383000
[No Abstract] [Full Text] [Related]
16. Moving towards patient-centered decision-making in chronic myeloid leukemia: assessment of quality of life and symptom burden.
Baccarani M; Efficace F; Rosti G
Haematologica; 2014 Feb; 99(2):205-8. PubMed ID: 24497557
[No Abstract] [Full Text] [Related]
17. EASIX and CPSS Cytogenetics score-based composite risk model for patients with CMML undergoing allogeneic transplant.
Baranwal A; Mangaonkar A; Shah MV; Al-Kali A; Tefferi A; Hogan WJ; Litzow MR; Patnaik MM; Alkhateeb HB
Bone Marrow Transplant; 2024 Apr; 59(4):558-560. PubMed ID: 38216690
[No Abstract] [Full Text] [Related]
18. Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report.
Diral E; Catalano G; Cicinelli MV; Distefano A; Mastaglio S; Vago L; Lupo Stanghellini MT; Bernardi M; Ponzoni M; Ciceri F; Carrabba MG
Front Oncol; 2024; 14():1399894. PubMed ID: 38756666
[TBL] [Abstract][Full Text] [Related]
19. CNL and aCML are prognostically distinct: a large National Cancer Database analysis.
Tremblay D; Sastow D; Mascarenhas J
Blood Adv; 2023 Aug; 7(16):4400-4402. PubMed ID: 37289504
[No Abstract] [Full Text] [Related]
20. Cabot rings in chronic myelomonocytic leukemia.
Strasser B; Haushofer A
Blood; 2023 Nov; 142(20):1757. PubMed ID: 37971756
[No Abstract] [Full Text] [Related]
[Next] [New Search]
